Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
Tick Talk: Addressing Misconceptions in Lyme Disease Diagnosis and Treatment - 2023Conf
  • Primary Care
  • FREE for Members
  • Infectious Disease
  • Pharmacology CE
  • 1.00 Contact hours
$0.00
1.0 NAPNAP Contact Hour, of which 025 contains pharmacology. This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members and non-members. This course is an archived presentation from NAPNAP's 2023 National Conference. Lyme disease is the most common vector-borne disease in the United States, with approximately 476,000 people diagnosed and treated each year. Pediatric-focused APRNs in both high- and low-incidence areas may encounter Lyme disease, particularly with endemic areas expanding and increased patient travel. A 2022 survey of more than 600 nurse practitioners and other health care providers revealed that the respondents do not have strong confidence in their Lyme disease knowledge, and provider knowledge gaps exist regarding the appropriate diagnosis and treatment of Lyme disease. This session will review key findings of this survey and address common misconceptions in the diagnosis and treatment of Lyme disease. NAPNAP was awarded funding for to support this education via CDC’s Mobilizing Pediatric Provider Networks: An Education and Training Initiative to Prevent and Control Infectious Disease Threats federal project.
Pick a Pill! Oral Contraceptive Pill Prescribing for Beginners - 2023Conf
  • Primary Care
  • Pharmacology CE
  • 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour of which 1.0 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10.00 for NAPNAP Members. For non-members, this continuing education activity rate is $20.00. This course is an archived presentation from NAPNAP's 2023 National Conference and is offered free with a coupon for conference attendees until 12/31/23.  Designed for early career pediatric-focused APRNs, this presentation will review key components of prescribing oral contraceptive pills. Both progestin-only and combined hormonal contraceptives will be included. Attendees will leave feeling confident in their ability to prescribe and manage adolescents who desire oral contraceptive pills for not only contraception, but also dysmenorrhea and acne management.
Atopic Dermatitis: Treatment Strategies and a Patient Experience with Dupilumab Therapy - 2023Conf
  • Primary Care
  • Pharmacology CE
  • 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is an archived presentation from NAPNAP's 2023 National Conference and is offered free with a coupon for conference attendees until 12/31/23.  Atopic dermatitis disease can vary from very mild to very severe. Proper treatment can be challenging even for the most seasoned provider. We will review case presentations with photos of mild, mild-moderate and severe atopic dermatitis management along with recommended treatment and pit fall strategies. This presentation will offer an online algorithm and newly developed app to guide the clinician in atopic dermatitis recommended care. Dupilumab biologic medication is transforming patients’ lives with moderate – severe atopic dermatitis. A patient’s experience with dupilumab treatment will be shared.
2023 Pediatric Rx, Module 1: What's New in Pediatric Pharmacology
  • Primary Care
  • Acute Care
  • Pharmacology
  • 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Current pediatric prescribing recommendations will be reviewed. An extensive review and update will provide the participant with an improved understanding of therapeutic benefits as well as potential risks of medications prescribed for children, including efficacy, safety and prescribing recommendations. Current MedWatch Safety Alerts issued by the FDA will also be covered.
2023 Pediatric RX, Module 2: Immunization Update
  • Primary Care
  • Acute Care
  • Infectious Disease
  • Pharmacology CE
  • 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Current information from CDC will be reviewed. Most current information about vaccine safety will also be covered.
2023 Pediatric Rx, Module 3- Respiratory Drugs
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • 1.25 Contact hours
$25.00
1.5 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non- members, this continuing education activity rate is $25. An extensive review will provide the participant with up-to-date information pharmacological management of common respiratory illnesses in children.
2023 Pediatric Rx, Module 4- The Use of Biologics
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This course will review the definition and regulation of the use of biologic agents in children and adolescents.
Autoimmune Diseases for Pediatric Primary Care Providers
  • Primary Care
  • Mental Health
  • 1.00 Contact hours
$30.00
1.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $15 for NAPNAP Members. For non-members, this continuing education activity rate is $30. This course will familiarize pediatric primary care providers with the identification and management of common rheumatologic diseases. Providers will gain a better understanding of the initial presenting symptoms of common pediatric autoimmune diseases, including juvenile idiopathic arthritis, systemic lupus erythematosus, IgA vasculitis, Kawasaki disease and rheumatic fever. Participants will gain a deeper understanding of the utility of laboratory evaluation and health promotion for this patient population.
Genetics for the Pediatric-focused APRN
  • Primary Care
  • Mental Health
  • 0.75 Contact hours
$15.00
0.75 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $ 7.50 for NAPNAP Members. For non-members, this continuing education activity rate is $15. This course will discuss the role of the pediatric-focused APRN in providing genomic-based care. We will review some basics of human genetics, genomics and patterns of genetic inheritance. We will use case studies to highlight the impact on genetic variants in pediatric conditions.
Pharmacogenetics for the Pediatric-focused APRN: Things you Vaguely Remember from Pharmacology
  • Primary Care
  • Mental Health
  • 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour, 1.0 Pharmacology This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $ 10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course will discuss principles of pharmacogenetics that are related to pediatric practice. This includes how genetic variants impact the patient’s experience with medications. We will use case studies to illustrate how pharmacogenetics may play a role in primary care mental health condition management.

Pages